Greenberg Traurig (New York)

Stephen M. Pepper

Greenberg Traurig (New York)

Stephen M. Pepper is a shareholder at Greenberg Traurig, LLP. He advises clients on the antitrust aspects of mergers, acquisitions and joint ventures. He has wide-ranging experience with the antitrust pre-acquisition reporting requirements of the Hart-Scott-Rodino (HSR) Act, including HSR Act implications of complex transactions involving private equity firms and hedge funds. He frequently advises clients on global merger clearance strategy for international transactions, including the coordination of international merger control filings and clearance efforts. Stephen has obtained antitrust clearance from the U.S. Department of Justice, the Federal Trade Commission, and foreign merger control authorities for transactions in a variety of industries, including healthcare, telecom and media, engineering, electronics, software, semiconductor equipment, chemicals, retail stores, food and beverage, banking, publishing, and consulting.


Linked authors

Greenberg Traurig (Washington)
Greenberg Traurig (Warsaw)
Greenberg Traurig (Warsaw)
Greenberg Traurig (Warsaw)
Greenberg Traurig (Warsaw)


431 Bulletin

Stephen M. Pepper The US District Court for the Eastern District of Louisiana rules that a $150M hospital merger is exempt from Hart-Scott-Rodino Act reporting obligations (Louisiana Children’s Medical Center / HCA Healthcare)


Louisiana federal court rules that Louisiana hospital merger is exempt from HSR Act obligations.* On Sept. 27, a Louisiana federal court ruled that Louisiana Children’s Medical Center (LCMC) and a large health care system did not need to report its $150 million merger transaction to the FTC (...)

Stephen M. Pepper The US FTC sues a private equity firm over an alleged anticompetitive scheme to suppress competition in anesthesiology practices through roll-up acquisitions (USAP / Welsh Carson)


FTC Sues Private Equity Fund and U.S. Anesthesia Partners Over Alleged ‘Roll Up’ Acquisitions, ‘Anticompetitive Scheme’* For the first time, the FTC has focused merger enforcement action on the so-called “roll up” strategy often employed by private equity firms investing in the health care (...)

Arthur J. Burke, Christopher B. Hockett, Howard Zhang, Joel M. Cohen, Michael N. Sohn, Miranda So, Ronan P. Harty, Stephen M. Pepper The US Court of Appeals for the Seventh Circuit potentially expands the extraterritorial reach of the US antitrust laws (Minn-Chem / Agrium)


This article has been nominated for the 2013 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Introduction The U.S. Court of Appeals for the Seventh Circuit (the “Court”) recently potentially expanded the extraterritorial reach of the U.S. antitrust (...)


Total visits

Number of readings per contribution

Number of contributions

Author's ranking
In number of contributions
In number of visits
In average number of visits
Send a message